Search Results
452 items found for "Regulator of G protein signaling 6"
- Endocannabinoid System in the Neuroendocrine Response to Lipopolysaccharide-induced Immune Challenge
endocannabinoid system plays a key role in the intersection of the nervous, endocrine, and immune systems, regulating Endogenous ligands, named endocannabinoids, are produced “on demand” to finely regulate the synthesis and secretion of hormones and neurotransmitters, as well as to regulate the production of cytokines
- Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell...
Immunohistochemistry, western blot and quantitative real-time PCR techniques were used to analyze β2-AR protein and mRNA levels in a total of 65 histopathologically confirmed OSCC tissues (case group) and 65 normal
- Lack of Oestrogen Receptor Expression in Breast Cancer Cells Does Not Correlate with Kisspeptin...
2022 Lack of Oestrogen Receptor Expression in Breast Cancer Cells Does Not Correlate with Kisspeptin Signalling To assess the veracity of this claim, we compared endogenous KISS1R signalling and physiological output
- Unconventional GPCR-PKA Communication in the Hedgehog Pathway
Learn about communication between GPCRs and PKA, Class F GPCR Smoothened & the Hedgehog signaling pathway
- Dr. Adriano Marchese - Dr. GPCR Podcast
Learn about his remarkable career and research in #GPCR signaling and trafficking.
- Time is your enemy, GPCRs are your friend
Stuart Maudsley on how an aging physiological context affects #GPCR signaling #drgpcr.
- Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid...
Immunoblotting approach was used to analyze signaling involved in fentanyl’s action focusing on EGFR.
- Neurotransmitters: Potential Targets in Glioblastoma
By targeting the receptors synaptically or non-synaptically, neurotransmitters activate multiple signaling
- Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand
August 2022 "Abstract Sigma receptor is a transmembrane non-GPCR protein expressed mainly in the endoplasmic compounds showed more than 50% displacement of the radioligand at 10 µM concentration with compound 6c Moreover, compounds 6c and 6e showed a significant selectivity over S2R.
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
September 2022 Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant CB2) is highly expressed in the immune system, emerging evidence points to CB2 playing a key role in regulating
- OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
yesterday for contributions to the field of mass spectrometry and establishing it as method to analyse proteins
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
Previous findings suggest that parallel pathways independently relay innate threat signals from different
- First in Human: Early-stage COVID therapies hold promise against omicron variant
partner GlaxoSmithKline PLC posted results Dec. 7 demonstrating activity against the omicron spike protein
- Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
inhibition of glutamate release from presynaptic nerve terminals and is also poised upstream of a myriad of signaling
- CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via...
interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via the PI3K/AKT signaling
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
September 2022 "Research on cancer therapies focuses on processes such as angiogenesis, cell signaling
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
development approaches include a range of techniques leveraging structural biology, immunology, cell signaling
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors
To validate these processes, we employed GIRK4S143T, a MOR-activated Gβγ-protein effector, in combination
- Novo Nordisk moves to strengthen obesity efforts
plan, the Danish giant will work with EraCal to identify novel drug targets relevant for food intake regulation
- Fly casting with ligand sliding and orientational selection supporting complex formation of a GPCR..
conducted to elucidate binding mechanisms of a middle-sized flexible molecule, bosentan, to a GPCR protein
- Dimerization of β2-adrenergic receptor is responsible for the constitutive activity subjected to inv
of monomeric β2-AR, unlike the inverse agonists, implying that the cholesterol is a specific factor regulating
- SLAS2022 International Conference and Exhibition
We are closely monitoring any regulation changes from both Boston and Massachusetts with regard to in-person
- Sweet taste receptor agonists attenuate macrophage IL‐1β expression and eosinophilic inflammation...
causal role in eosinophilic CRS (ECRS) via macrophage IL‐1β overproduction, thereby suggesting autophagy regulation
- Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...
Modulator Screening Platform Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 6,
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
Major conformational differences were located on transmembrane (TM) 5 and 6, as well as intracellular
- Molecular basis for variations in the sensitivity of pathogenic rhodopsin variants to 9-cis-retinal
We identify 69 retinopathy variants, including 20 previously uncharacterized variants, that exhibit diminished Of these apparent class II variants, 67 exhibit a measurable increase in expression in the presence of
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
Orally bioavailable compound 47 with favorable agonist potency (Ca2+EC50 = 24 nM, cAMPi EC50 = 6.5 nM
- Addex Raises $10 Million In Equity Financing
institutional investor, pursuant to which the Company agreed to sell 3,752,202 shares in the form of 625,367 American Depositary Shares (“ADSs”) at a gross purchase price of $6.50 per ADS, which is equivalent The Unregistered Warrants have an exercise price of $6.50 per ADS, will become exercisable in 60 days The Unregistered Pre-Funded Warrants have been funded to the amount of $6.49 with $0.01 payable on exercise